株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

イスラエルのライフサイエンス市場分析

Israel Life Sciences Market Analysis

発行 RNCOS E-Services Pvt. Ltd. 商品コード 200502
出版日 ページ情報 英文 55 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
イスラエルのライフサイエンス市場分析 Israel Life Sciences Market Analysis
出版日: 2011年06月01日 ページ情報: 英文 55 Pages
概要

ライフサイエンス分野はイスラエルにおいて主要なビジネスのひとつとなっており、イスラエルのライフサイエンス業界では毎年平均40社が新たに設立され、700社を超える企業があります。広範な学術研究、早期段階研究に対する政府の手厚い支援、教育のニーズと技術革新などが、過去数年のイスラエルのライフサイエンス業界の成長を押し上げています。

当レポートでは、イスラエルのライフサイエンス業界の現状と政府の取り組み、マクロ経済因子、市場の機会と戦略などをまとめ、概略以下の構成でお届けします。

第1章 アナリストの見解

第2章 調査方法

第3章 イスラエル:経済指標と競合力

第4章 市場促進因子

  • 優れた学術環境
  • 学術機関、研究機関、企業との連携
  • 世界の技術革新を通じた認知度
  • カスタマイズされた研究インフラ
  • 政府の取り組み

第5章 イスラエルのライフサイエンス業界:概要

  • 市場規模と成長
  • 市場因子
    • 医療機器
    • バイオテクノロジー
    • 医薬品
    • アグロバイオテクノロジー
    • 医療用IT
  • 治療別セグメンテーション
  • 輸出

第6章 投資シナリオ

第7章 近年のM&A活動

第8章 競合環境

  • Perrigo Pharmaceuticals Ltd.
  • Roche
  • Merck & Co.
  • Sun Pharmaceutical
  • GE Healthcare
  • Teva Pharmaceutical Industries Limited

図表一覧

目次

Abstract

The field of life sciences has stipulated itself as one of the major businesses in Israel. The Israeli Life Sciences Industry boasts of over 700 companies with 40 companies being formed every year on an average. Extensive academic research, significant government support of early-stage research, rising demand for education and technological innovations are some of the factors that have been fueling growth in the Israeli Life Sciences Industry for the past few years.

As per our report "Israel Life Sciences Market Analysis", Israeli companies have been joined by leading multinationals in making Israel a recognized force in the Life Sciences industry worldwide. Global giants, including J&J, Perrigo, GE Healthcare, Phillips Healthcare, together with local companies, such as Teva, itself now a multi-national company, Given Imaging, Insightec, Medinol, Disc-o-tech, Brainstorm and others have been continuously developing and marketing life changing medical breakthroughs and innovations in the country.

Our study indicates that, in 2010, medical devices formed the major part of the life sciences industry with a share of more than half of the life sciences company working in this segment. Israel' s strength in the segment curtails from inter-disciplinary competence, which brings together medicine, clinical proficiency, materials science, electronics, software capability, and engineering know-how.

The other major segment of businesses in life sciences includes biotech, medical IT & pharma. Our study indicates that, despite the fact that, Israeli biotechnology has a hold on the entire biotech field ranging from animal vaccines and diagnostics to plant tissue culture, bioreactors, seeds, diagnostics and biopesticides, its focus over the past few years has been mainly on biopharma, diagnostics and cell- and tissue-therapies.

Our report "Israel Life Sciences Market Analysis" highlights the Israeli Life Sciences Industry by segmenting it into medical devices, biotechnology, pharma, medical IT & Agro Biotech. Each of these segments have been thoroughly studied and analyzed in the report. Moreover, the report provides an overview of the investment scenario and recent M&As activity, which will help clients in identifying the future demand scenario.

The report studies the current market drivers and its effects on the incessant growth of the industry. The research contains exhaustive information about the market players, government initiatives, and macro-economic indicators that will help clients to draw up market strategies and assess opportunity areas in the Israeli Life Sciences Industry.

The report also includes a section of exports and analysis by therapeutics that presents a rough idea about the prospective business trends to facilitate clients comprehend, how the market will progress in coming years.

Table of Contents

1. Analyst View

2. Research Methodology

3. Israel: Economic Indicators & Competitive Edge

4. Market Drivers

  • 4.1 Excellent Academic Environment
  • 4.2 Co-operation among Academia, Research & Business
  • 4.3 Global Recognition through Innovations
  • 4.4 Customized Research Infrastructure
  • 4.5 Government Initiatives

5. Israel Life Sciences Industry: An Overview

  • 5.1 Market Size and Growth
  • 5.2 Market Sectors
    • 5.2.1 Medical Devices
    • 5.2.2 Biotechnology
    • 5.2.3 Pharmaceutical
    • 5.2.4 AgroBiotech
    • 5.2.5 Medical IT
  • 5.3 Segmentation by Therapeutics
  • 5.4 Exports

6. Investments Scenario

7. Recent M&A Activity

8. Competitive Landscape

  • 8.1 Perrigo Pharmaceuticals Ltd.
  • 8.2 Roche
  • 8.3 Merck & Co.
  • 8.4 Sun Pharmaceutical
  • 8.5 GE Healthcare
  • 8.6 Teva Pharmaceutical Industries Limited

List of Figures:

  • Figure 4-1: Number of Ph.D. Graduates (2003-04 & 2008-09)
  • Figure 4-2: Global - Number of Scientific Publications & Citations of Leading Countries (per Million Inhabitants)
  • Figure 4-3: Chief Scientist Grants by Technological Sectors (%), 2009
  • Figure 4-4: Chief Scientist Grants in Life Sciences Industry (Million US$), 2007-2010
  • Figure 4-5: Chief Scientist Grants in Life Sciences Industry by Sector (%), 2010
  • Figure 4-6: Incubated Companies by Sector (%)
  • Figure 5-1: Number of Companies Founded in Life Sciences Industry (2005-2009)
  • Figure 5-2: Life Sciences Companies by Sector (%), 2010
  • Figure 5-3: Medical Devices Companies by Sub-Sector (%), 2010
  • Figure 5-4: Clinical Trials of New Molecules in Biopharma by Phase (%), 2010
  • Figure 5-5: Pharmaceutical Companies by Sub-Sector (%), 2010
  • Figure 5-6: Life Sciences Companies by Therapeutics (%), 2010
  • Figure 5-7: Life Sciences Export (Billion US$), 2008 & 2009
  • Figure 5-8: Life Sciences Export by Countries (%), Q1 2010

List of Tables:

  • Table 3-1: Major Economic Indicators (2007-2010)
  • Table 3-2: Israel' s Competitiveness Ranking (2010)
  • Table 4-1: Recipients of Academic Degrees in Life Sciences (Number), 2007-08
  • Table 4-2: List of Blockbuster Launched Products by Company
  • Table 5-1: Biotech Companies by Sub-Sector (%), 2010
  • Table 6-1: Life Sciences Industry Financing by Source (Million US$), 2010
  • Table 7-1: Mergers & Acquisitions in Life Sciences Industry (Million US$), 2008 to 2011
Back to Top